Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Meningococcal Vaccines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Meningococcal Vaccinesmarket, defines the market attractiveness level of Meningococcal Vaccines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Meningococcal Vaccines industry, describes the types of Meningococcal Vaccines market, the applications of major players and the market size, and deeply analyzes the current situation of the global Meningococcal Vaccines market and the development prospects and opportunities of Meningococcal Vaccines industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Meningococcal Vaccines market in Chapter 13.
By Player:
Novartis International
Sanofi
Pfizer
GlaxoSmithKline
Baxter International
JN-International Medical
By Type:
Menactra
Menomune
By End-User:
Pneumonia
Meningitis
Bacteremia
Others (Arthritis, Conjunctivitis, Urethritis)
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Meningococcal Vaccines Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Meningococcal Vaccines Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Meningococcal Vaccines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Meningococcal Vaccines Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Meningococcal Vaccines Market Analysis and Outlook to 2022
-
7.1 Global Meningococcal Vaccines Consumption (2017-2022)
-
7.2 United States Meningococcal Vaccines Consumption (2017-2022)
-
7.3 Europe Meningococcal Vaccines Consumption (2017-2022)
-
7.4 China Meningococcal Vaccines Consumption (2017-2022)
-
7.5 Japan Meningococcal Vaccines Consumption (2017-2022)
-
7.6 India Meningococcal Vaccines Consumption (2017-2022)
-
7.7 South Korea Meningococcal Vaccines Consumption (2017-2022)
8 Region and Country-wise Meningococcal Vaccines Market Analysis and Outlook to 2028
-
8.1 Global Meningococcal Vaccines Consumption Forecast (2022-2028)
-
8.2 United States Meningococcal Vaccines Consumption Forecast (2022-2028)
-
8.3 Europe Meningococcal Vaccines Consumption Forecast (2022-2028)
-
8.4 China Meningococcal Vaccines Consumption Forecast (2022-2028)
-
8.5 Japan Meningococcal Vaccines Consumption Forecast (2022-2028)
-
8.6 India Meningococcal Vaccines Consumption Forecast (2022-2028)
-
8.7 South Korea Meningococcal Vaccines Consumption Forecast (2022-2028)
9 Global Meningococcal Vaccines Market Outlook by Types and Applications to 2022
-
9.1 Global Meningococcal Vaccines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Menactra Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Menomune Consumption and Growth Rate (2017-2022)
-
9.2 Global Meningococcal Vaccines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Pneumonia Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Meningitis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Bacteremia Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others (Arthritis, Conjunctivitis, Urethritis) Consumption and Growth Rate (2017-2022)
10 Global Meningococcal Vaccines Market Outlook by Types and Applications to 2028
-
10.1 Global Meningococcal Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Menactra Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Menomune Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Meningococcal Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Pneumonia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Meningitis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Bacteremia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others (Arthritis, Conjunctivitis, Urethritis) Consumption Forecast and Growth Rate (2022-2028)
11 Global Meningococcal Vaccines Import and Export Analysis (Top 5 Countries)
-
11.1 Global Meningococcal Vaccines Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Meningococcal Vaccines Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Meningococcal Vaccines Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Meningococcal Vaccines Market Competitive Analysis
-
14.1 Novartis International
-
14.1.1 Novartis International Company Details
-
14.1.2 Novartis International Meningococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis International Meningococcal Vaccines Product and Service
-
14.2 Sanofi
-
14.2.1 Sanofi Company Details
-
14.2.2 Sanofi Meningococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sanofi Meningococcal Vaccines Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Meningococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Meningococcal Vaccines Product and Service
-
14.4 GlaxoSmithKline
-
14.4.1 GlaxoSmithKline Company Details
-
14.4.2 GlaxoSmithKline Meningococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlaxoSmithKline Meningococcal Vaccines Product and Service
-
14.5 Baxter International
-
14.5.1 Baxter International Company Details
-
14.5.2 Baxter International Meningococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Baxter International Meningococcal Vaccines Product and Service
-
14.6 JN-International Medical
-
14.6.1 JN-International Medical Company Details
-
14.6.2 JN-International Medical Meningococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 JN-International Medical Meningococcal Vaccines Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Meningococcal Vaccines
-
Figure Meningococcal Vaccines Picture
-
Table Global Meningococcal Vaccines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Meningococcal Vaccines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Meningococcal Vaccines Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Meningococcal Vaccines Consumption by Country (2017-2022)
-
Figure United States Meningococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Table Europe Meningococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure China Meningococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Japan Meningococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure India Meningococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Korea Meningococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Meningococcal Vaccines Consumption Forecast by Country (2022-2028)
-
Figure United States Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Meningococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Menactra Consumption and Growth Rate (2017-2022)
-
Figure Global Menomune Consumption and Growth Rate (2017-2022)
-
Figure Global Pneumonia Consumption and Growth Rate (2017-2022)
-
Figure Global Meningitis Consumption and Growth Rate (2017-2022)
-
Figure Global Bacteremia Consumption and Growth Rate (2017-2022)
-
Figure Global Others (Arthritis, Conjunctivitis, Urethritis) Consumption and Growth Rate (2017-2022)
-
Figure Global Menactra Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Menomune Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pneumonia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Meningitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bacteremia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others (Arthritis, Conjunctivitis, Urethritis) Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Meningococcal Vaccines Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Meningococcal Vaccines Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis International (Foundation Year, Company Profile and etc.)
-
Table Novartis International Meningococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis International Meningococcal Vaccines Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Meningococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Meningococcal Vaccines Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Meningococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Meningococcal Vaccines Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Meningococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Meningococcal Vaccines Product and Service
-
Table Baxter International (Foundation Year, Company Profile and etc.)
-
Table Baxter International Meningococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter International Meningococcal Vaccines Product and Service
-
Table JN-International Medical (Foundation Year, Company Profile and etc.)
-
Table JN-International Medical Meningococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table JN-International Medical Meningococcal Vaccines Product and Service
-
